Statistics
Total Visits
Views | |
---|---|
Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792) | 180 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792) | 1 | 0 | 5 | 14 | 5 | 8 | 0 |
Top country views
Views | |
---|---|
United States | 65 |
Poland | 64 |
Cyprus | 10 |
China | 8 |
India | 5 |
Ireland | 4 |
Australia | 1 |
France | 1 |
Greece | 1 |
Macedonia | 1 |
Top cities views
Views | |
---|---|
Warsaw | 64 |
Menlo Park | 12 |
Louisville | 11 |
Limassol | 10 |
San Ramon | 6 |
Villa Park | 6 |
Boardman | 5 |
Beijing | 4 |
Philadelphia | 4 |
Ashburn | 3 |